CA Stock MarketDetailed Quotes

ATE Antibe Therapeutics Inc

Watchlist
  • 0.295
  • 0.0000.00%
15min DelayMarket Closed Apr 10 09:30 ET
15.64MMarket Cap-842P/E (TTM)

Antibe Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CAD
2020/FY
Stock NameRevenueRatio
Citagenix9.67M100.00%
Product

No Data

Industry

No Data

Region Currency:CAD
2018/FY
Stock NameRevenueRatio
Canada, United States and Germany8.51M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg